Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Jun 20;8(25):39941-39942.
doi: 10.18632/oncotarget.17990.

APOE genotype and Alzheimer's immunotherapy

Affiliations
Editorial

APOE genotype and Alzheimer's immunotherapy

Joanna E Pankiewicz et al. Oncotarget. .
No abstract available

Keywords: Alzheimer’s disease; amyloid related imaging abnormalities; apolipoprotein E; b-amyloid; microglia.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Interaction between APOE genotype, Aβ deposition, and microglia
The APOE ε4 allele is associated with greater β-amyloid (Aβ) deposition than APOE ε2 and ε3 alleles. Aβ parenchymal plaques attract microglia cells and cause their peri-plaque activation, which is proportional to Aβ plaque load across all APOE genotypes. Therapeutic anti-Aβ monoclonal antibodies (mAbs) bind deposited Aβ and activate microglia cells to clear Aβ through Fc receptor-mediated phagocytosis. The APOE ε4 allele is associated with greater microglia activation than APOE alleles ε2 and ε3 resulting in greater clearance of Aβ plaque load during Aβ-directed passive immunization.

References

    1. Corder EH, et al. Science. 1993;261:921–923. - PubMed
    1. Liu CC, et al. Nat Rev Neurol. 2013;9:106–118. - PMC - PubMed
    1. Salloway S, et al. Neurology. 2009;73:2061–2070. - PMC - PubMed
    1. Sperling R, et al. Lancet Neurol. 2012;11:241–249. - PMC - PubMed
    1. Salloway S, et al. N Engl J Med. 2014;370:322–33. - PMC - PubMed

Publication types

LinkOut - more resources